368 related articles for article (PubMed ID: 29698975)
1. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
[TBL] [Abstract][Full Text] [Related]
2. Microangiopathic Lesions in IgA Nephropathy: A Cohort Study.
Cai Q; Shi S; Wang S; Ren Y; Hou W; Liu L; Lv J; Haas M; Zhang H
Am J Kidney Dis; 2019 Nov; 74(5):629-639. PubMed ID: 31103332
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy.
Wu J; Chen X; Xie Y; Yamanaka N; Shi S; Wu D; Liu S; Cai G
Nephrol Dial Transplant; 2005 Apr; 20(4):719-27. PubMed ID: 15701667
[TBL] [Abstract][Full Text] [Related]
4. Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis.
Sugiura N; Moriyama T; Miyabe Y; Karasawa K; Nitta K
J Pathol Clin Res; 2021 Nov; 7(6):616-623. PubMed ID: 34185389
[TBL] [Abstract][Full Text] [Related]
5. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Nagata M; Tsuchimoto A; Hirakata H; Kitazono T; Tsuruya K
Clin Exp Nephrol; 2016 Oct; 20(5):689-698. PubMed ID: 26564155
[TBL] [Abstract][Full Text] [Related]
6. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
Riispere Ž; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
BMC Nephrol; 2017 Mar; 18(1):89. PubMed ID: 28292274
[TBL] [Abstract][Full Text] [Related]
7. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
8. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
Li X; Liu Y; Lv J; Shi S; Liu L; Chen Y; Zhang H
Clin J Am Soc Nephrol; 2014 Mar; 9(3):484-9. PubMed ID: 24408121
[TBL] [Abstract][Full Text] [Related]
9. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics, risk factors and prognostic value of intrarenal vascular lesions in IgA nephropathy.
Ruan Y; Hong F; Lin M; Wang C; Lian F; Cao F; Yang G; Huang L; Huang Q
Eur J Intern Med; 2023 Nov; 117():91-97. PubMed ID: 37451907
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
Huang Z; Hu Y; Chen B; Liang Y; Li D; Qiu W; Zhang J; Chen C
J Nephrol; 2023 Mar; 36(2):429-440. PubMed ID: 36538201
[TBL] [Abstract][Full Text] [Related]
12. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
[TBL] [Abstract][Full Text] [Related]
13. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
17. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
Bazzi C; Rizza V; Casellato D; Stivali G; Rachele G; Napodano P; Olivieri G; Gallieni M; D'Amico G
J Nephrol; 2012; 25(5):810-8. PubMed ID: 22252844
[TBL] [Abstract][Full Text] [Related]
18. Arteriolar hyalinosis and arterial hypertension as possible surrogate markers of reduced interstitial blood flow and hypoxia in glomerulonephritis.
Bazzi C; Stivali G; Rachele G; Rizza V; Casellato D; Nangaku M
Nephrology (Carlton); 2015 Jan; 20(1):11-7. PubMed ID: 25230383
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression in IgA Nephropathy in Childhood.
Mizerska-Wasiak M; Małdyk J; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Bieniaś B; Zajączkowska M; Miklaszewska M; Pietrzyk J; Demkow U; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of renin-angiotensin system inhibitors (RASI) on IgA nephropathy with tubulointerstitial lesions categorized by Oxford classification.
Kamiyama T; Moriyama T; Kumon S; Karasawa K; Nitta K
Clin Exp Nephrol; 2019 Jun; 23(6):834-840. PubMed ID: 30796546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
